Literature DB >> 17160528

Office capillaroscopy in systemic sclerosis.

Murray Baron1, Mary Bell, Arthur Bookman, Maura Buchignani, James Dunne, Marie Hudson, Dana Jerome, Sindhu R Johnson, Niall Jones, Elzbieta Kaminska, Terri Lupton, Jean-Pierre Mathieu, Janet Pope, Russell Steele, Suzanne Taillefer.   

Abstract

The aims of this study are to assess the reliability of two office techniques, the ophthalmoscope and the Dermlite dermatoscope, and to detect nailfold capillaroscopy abnormalities in systemic sclerosis (SSc). Two separate studies were performed. In the first, the nailfolds of two fingers on one hand of 13 SSc patients and two normals were examined by four rheumatologists using an ophthalmoscope. In the second, the nailfolds of the two fingers of each hand of six SSc patients and two normals were examined by six rheumatologists with a Dermlite dermatoscope. Widefield capillary microscopy was performed by one observer in the ophthalmoscope study to assess validity. The examiners determined the presence or absence of dilated loops, giant capillary loops, and/or avascular areas on each digit. The kappa coefficient was calculated to demonstrate agreement. With the ophtalmoscope, the inter-observer kappa coefficients were 0.43, 0.54, and 0.19; the average intra-observer agreements were 0.61, 0.56, and 0.31; and the ophthalmoscope-microscope agreement were 0.63, 0.52, and <0.1 for dilated capillaries, giant capillaries, and avascular areas, respectively. With the dermatoscope, the kappa values for inter-observer reliability were 0.63, 0.40, and 0.20; and intra-observer reliability was 0.71, 0.55, and 0.40 for dilated capillaries, giant capillaries, and avascular areas, respectively. The ophthalmoscope and the dermatoscope provide moderate to substantial reliability to detect the presence of giant and dilated capillaries but poor inter-observer agreement for avascular areas. The ophthalmoscope is valid when compared to the microscope for detecting giant or dilated capillaries. We conclude that these techniques are useful office tools to detect capillary abnormalities in SSc.

Entities:  

Mesh:

Year:  2006        PMID: 17160528     DOI: 10.1007/s10067-006-0489-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  31 in total

Review 1.  The kappa statistic in rehabilitation research: an examination.

Authors:  Leigh R Tooth; Kenneth J Ottenbacher
Journal:  Arch Phys Med Rehabil       Date:  2004-08       Impact factor: 3.966

Review 2.  Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.

Authors:  H R Maricq
Journal:  Arch Dermatol       Date:  1992-05

3.  Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.

Authors:  M Cutolo; A Sulli; C Pizzorni; S Accardo
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

4.  Patterns of finger capillary abnormalities in connective tissue disease by "wide-field" microscopy.

Authors:  H R Maricq; E C LeRoy
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

Review 5.  Microvasculature in systemic sclerosis.

Authors:  P H Carpentier; H R Maricq
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

6.  Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases.

Authors:  J G Kenik; H R Maricq; G G Bole
Journal:  Arthritis Rheum       Date:  1981-07

7.  Office nail fold capillary microscopy using ophthalmoscope.

Authors:  W Minkin; N B Rabhan
Journal:  J Am Acad Dermatol       Date:  1982-08       Impact factor: 11.527

8.  Capillary morphology and the course of illness in schizophrenic patients.

Authors:  H R Maricq
Journal:  J Nerv Ment Dis       Date:  1966-01       Impact factor: 2.254

9.  Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma.

Authors:  L S Lonzetti; F Joyal; J P Raynauld; A Roussin; J R Goulet; E Rich; D Choquette; Y Raymond; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-03

10.  Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon.

Authors:  H R Maricq; A B Weinberger; E C LeRoy
Journal:  J Rheumatol       Date:  1982 Mar-Apr       Impact factor: 4.666

View more
  11 in total

Review 1.  The pathogenesis, diagnosis and treatment of Raynaud phenomenon.

Authors:  Ariane L Herrick
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

2.  A portable dermatoscope for easy, rapid examination of periungual nailfold capillary changes in patients with systemic sclerosis.

Authors:  Eiji Muroi; Toshihide Hara; Koichi Yanaba; Fumihide Ogawa; Ayumi Yoshizaki; Motoi Takenaka; Kazuhiro Shimizu; Shinichi Sato
Journal:  Rheumatol Int       Date:  2010-05-27       Impact factor: 2.631

3.  Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon.

Authors:  Rebecca Overbury; Maureen A Murtaugh; Aryeh Fischer; Tracy M Frech
Journal:  Clin Rheumatol       Date:  2015-09-23       Impact factor: 2.980

4.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

5.  Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.

Authors:  Jaap Fransen; Sindhu R Johnson; Frank van den Hoogen; Murray Baron; Yannick Allanore; Patricia E Carreira; László Czirják; Christopher P Denton; Oliver Distler; Daniel E Furst; Armando Gabrielli; Ariane Herrick; Murat Inanc; Bashar Kahaleh; Otylia Kowal-Bielecka; Thomas A Medsger; Ulf Mueller-Ladner; Gabriela Riemekasten; Stanislaw Sierakowski; Gabriele Valentini; Doug Veale; Madelon C Vonk; Ulrich Walker; Lorinda Chung; Philip J Clements; David H Collier; Mary E Csuka; Sergio Jimenez; Peter A Merkel; James R Seibold; Richard Silver; Virginia Steen; Alan Tyndall; Marco Matucci-Cerinic; Janet E Pope; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

Review 6.  Evidence-based management of Raynaud's phenomenon.

Authors:  Ariane L Herrick
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-20       Impact factor: 5.346

7.  Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.

Authors:  Murray Baron; Janet Pope; David Robinson; Niall Jones; Nader Khalidi; Peter Docherty; Elzbieta Kaminska; Ariel Masetto; Evelyn Sutton; Jean-Pierre Mathieu; Sophie Ligier; Tamara Grodzicky; Sharon LeClercq; Carter Thorne; Geneviève Gyger; Douglas Smith; Paul R Fortin; Maggie Larché; Maysan Abu-Hakima; Tatiana S Rodriguez-Reyna; Antonio R Cabral-Castaneda; Marvin J Fritzler; Mianbo Wang; Marie Hudson
Journal:  Rheumatology (Oxford)       Date:  2016-09-04       Impact factor: 7.580

8.  Raynaud's phenomenon.

Authors:  Ashraful Haque; Michael Hughes
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

Review 9.  The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications.

Authors:  Sophie P Toya; George E Tzelepis
Journal:  Rheumatol Int       Date:  2009-02-27       Impact factor: 2.631

Review 10.  The development of systemic sclerosis classification criteria.

Authors:  Jennifer G Walker; Janet Pope; Murray Baron; Sharon Leclercq; Marie Hudson; Suzanne Taillefer; Steven M Edworthy; Oleg Nadashkevich; Marvin J Fritzler
Journal:  Clin Rheumatol       Date:  2007-02-07       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.